CAMBRIDGE, England--(BUSINESS WIRE)--Today Wednesday 6th June 2012, Isogenica and Biolauncher, Cambridge UK together with Cresset Group, Welwyn Garden City UK announce funding from the Technology Strategy Board, the UK’s innovation agency, for a £1M project to develop a highly-scalable approach to small molecule drug discovery.
